NTUS - Natus Medical appoints new CEO
Natus Medical (NASDAQ:NTUS) announced executive transition after the company’s former CEO, Jonathan A. Kennedy, resigned. The medical device company has appointed Thomas J. Sullivan as its new President & CEO effective December 27. An industry veteran with over 20 years of experience, Mr. Sullivan served Spectrum Plastics Group as its President & CEO before joining Natus (NTUS). Prior to that, he held executive roles at Johnson & Johnson (NYSE:JNJ) from 1990 to 2011. In a separate regulatory filing, Natus (NTUS) announced the resignation of Jonathan A. Kennedy as its President & CEO effective December 13. His departure was not due to any disagreement between Mr. Kennedy and the company, Natus (NTUS) said. “The Board would like to thank Jonathan Kennedy for successfully positioning the Company for its next phase of innovation and growth,” Chairman of The Board, Joshua H. Levine, remarked.
For further details see:
Natus Medical appoints new CEO